LISANTI, CAMILLA
 Distribuzione geografica
Continente #
NA - Nord America 900
EU - Europa 145
AS - Asia 124
AF - Africa 1
Totale 1.170
Nazione #
US - Stati Uniti d'America 897
SG - Singapore 57
IT - Italia 52
CN - Cina 34
VN - Vietnam 21
DE - Germania 18
BE - Belgio 17
IE - Irlanda 13
UA - Ucraina 13
IN - India 9
GB - Regno Unito 8
FI - Finlandia 7
CZ - Repubblica Ceca 4
RU - Federazione Russa 4
CA - Canada 3
FR - Francia 3
IR - Iran 3
LT - Lituania 2
AL - Albania 1
EG - Egitto 1
NL - Olanda 1
NO - Norvegia 1
RO - Romania 1
Totale 1.170
Città #
Chandler 127
Fairfield 97
Ashburn 83
Ann Arbor 74
Singapore 56
Woodbridge 48
Seattle 46
Houston 44
Wilmington 33
Cambridge 30
New York 26
Beijing 23
Boardman 22
Dong Ket 21
Brussels 17
Princeton 17
Dublin 13
Dearborn 12
San Diego 11
Jacksonville 9
Martignacco 9
Redmond 8
Helsinki 7
Ogden 7
Washington 7
Augusta 5
Dallas 4
Leawood 4
Munich 4
Udine 4
Brno 3
Jinan 3
Los Angeles 3
Toronto 3
Ardabil 2
Clifton 2
Des Moines 2
Edinburgh 2
Frankfurt am Main 2
Kunming 2
Norwalk 2
Redwood City 2
Sagrado 2
San Mateo 2
Trieste 2
Asti 1
Bangalore 1
Cairo 1
Catania 1
Duncan 1
Hyderabad 1
Jinhua 1
Langfang 1
London 1
Melfi 1
Mortegliano 1
Mumbai 1
Nanchang 1
Nantong 1
Naples 1
Partanna 1
Phoenix 1
Prague 1
Romans 1
Rutigliano 1
San Remo 1
Santa Clara 1
Tirana 1
Trento 1
Tuenno 1
Venezia 1
Wenzhou 1
Totale 929
Nome #
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 123
Third-generation tyrosine kinase inhibitor in the treatment of epidermal growth factor receptor mutated squamous cell lung cancer: a tailored therapy approach 114
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 102
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 91
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) 91
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma 85
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 83
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition 82
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 71
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 69
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 65
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 51
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 43
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer 40
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World 38
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 37
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 33
Integration of Cellular and Humoral Immune Responses as an Immunomonitoring Tool for SARS-CoV-2 Vaccination in Healthy and Fragile Subjects 9
Totale 1.227
Categoria #
all - tutte 5.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.673


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020211 0 0 0 0 0 25 22 33 53 39 27 12
2020/2021292 15 25 43 31 20 8 9 37 6 24 35 39
2021/2022181 16 23 0 4 7 1 12 7 2 22 70 17
2022/2023234 20 35 2 29 32 44 0 25 28 3 11 5
2023/2024152 12 4 9 9 29 54 0 6 10 3 1 15
2024/2025105 11 23 10 28 33 0 0 0 0 0 0 0
Totale 1.227